Keyword search (4,163 papers available)

"Selby P" Authored Publications:

Title Authors PubMed ID
1 Management of brain-heart multimorbidity: a clinical practice guideline Edwards JD; Li Z; McFarlane P; Rabi DM; Gilbert J; Bajaj HS; MacIntosh BJ; Bittman J; Feldman RD; Dresser G; Terenzi K; Swartz R; Gabor J; Pearson GJ; Selby P; Wharton S; Warburton DER; Pakhalé S; Styra R; Baker B; Tu K; Hawkins M; Stone JA; Vaillancourt T; Poon S; Virani SA; Jain R; Jones PH; Sandhu RK; Ganesh A; Andrade JG; Stern S; Habert J; Rivard L; Roumeliotis P; Udell JA; Campbell T; Bacon SL; Trudeau L; Keshavjee K; Pham T; Cheng G; Lewis KB; Maar M; Stacey D; Oldenburg B; Dhukai AR; Pasricha SV; Sh 41912243
HKAP
2 The health effects of vaping and e-cigarettes: consensus recommendations Kouzoukas E; Navas C; Zawertailo L; Fougere C; Bacon SL; Chadi N; Evans WK; McNeill A; Melamed O; Moraes TJ; Nnorom O; Schwartz R; Shahab L; Ween M; Selby P; 41443121
HKAP
3 Ligne directrice C-CHANGE pour l’harmonisation des lignes directrices nationales de prévention et de prise en charge des maladies cardiovasculaires en contexte de soins primaires au Canada: mise à jour 2022 Jain R; Stone JA; Agarwal G; Andrade JG; Bacon SL; Bajaj HS; Baker B; Cheng G; Dannenbaum D; Gelfer M; Habert J; Hickey J; Keshavjee K; Kitty D; Lindsay P; L' Abbé MR; Lau DCW; Macle L; McDonald M; Nerenberg K; Pearson GJ; Pham T; Poppe AY; Rabi DM; Sherifali D; Selby P; Smith E; Stern S; Thanassoulis G; Terenzi K; Tu K; Udell J; Virani SA; Ward RA; Warburton DER; Wharton S; Zymantas J; Hua-Stewart D; Liu PP; Tobe SW; 36623864
HKAP
4 Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update Jain R; Stone JA; Agarwal G; Andrade JG; Bacon SL; Bajaj HS; Baker B; Cheng G; Dannenbaum D; Gelfer M; Habert J; Hickey J; Keshavjee K; Kitty D; Lindsay P; L' Abbé MR; Lau DCW; Macle L; McDonald M; Nerenberg K; Pearson GJ; Pham T; Poppe AY; Rabi DM; Sherifali D; Selby P; Smith E; Stern S; Thanassoulis G; Terenzi K; Tu K; Udell J; Virani SA; Ward RA; Warburton DER; Wharton S; Zymantas J; Hua-Stewart D; Liu PP; Tobe SW; 36343954
HKAP
5 Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Laroc 27118291
HKAP
6 Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell 28449828
HKAP
7 Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP 30301743
HKAP

 

Title:The health effects of vaping and e-cigarettes: consensus recommendations
Authors:Kouzoukas E,  Navas C,  Zawertailo L,  Fougere C,  Bacon SL,  Chadi N,  Evans WK,  McNeill A,  Melamed O,  Moraes TJ,  Nnorom O,  Schwartz R,  Shahab L,  Ween M,  Selby P
Link:https://pubmed.ncbi.nlm.nih.gov/41443121/
DOI:10.1016/j.drugpo.2025.105117
Publication:The International journal on drug policy
Keywords:Consensus;  E-cigarettes;  Guidance;  Nicotine;  Public health;  Vapes; 
PMID:41443121 Category: Date Added:2025-12-25
Dept Affiliation: HKAP
1 INTREPID Lab, Addictions Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.
2 INTREPID Lab, Addictions Program, Centre for Addiction and Mental Health, Toronto, ON, Canada; Institute for Mental Health Policy Research, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
3 Department of Health, Kinesiology, and Applied Physiology, Concordia University, Montreal, QC, Canada; Montreal Behavioural Medicine Centre, Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal (CIUSSS-NIM), Montreal, QC, Canada.
4 Division of Adolescent Medicine, Department of Pediatrics, Sainte-Justine University Hospital Centre, Montreal, QC, Canada; Department of Pediatrics, University of Montreal, Montreal, QC, Canada.
5 Department of Oncology, McMaster University, Hamilton, ON, Canada; Ontario Health (Cancer Care Ontario), Clinical Lead, Smoking Cessation, Primary and Community-based Care, ON, Canada.
6 Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
7 INTREPID Lab, Addictions Program, Centre for Addiction and Mental Health, Toronto, ON, Canada; Institute for Mental Health Policy Research, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
8 Division of Respiratory Medicine, Department of Pediatrics, SickKids & University of Toronto, Toronto, ON, Canada.
9 INTREPID Lab, Addictions Program, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
10 Institute for Mental Health Policy Research, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
11 Department of Behavioural Science and Health, Institute of Population Health, University College London, London, UK.
12 Department of Thoracic Medicine, Royal Adelaide Hospital, South Australia, Australia; School of Medicine, University of Adelaide, South Australia, Australia.
13 INTREPID Lab, Addictions Program, Centre for Addiction and Mental Health, Toronto, ON, Canada; Institute for Mental Health Policy Research, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: peter.selby@camh.ca.

Description:

Objective: To develop evidence-informed recommendations on the health effects of e-cigarettes to guide healthcare practitioners and the public to balance individual and population harm reduction.

Methods: Systematic and umbrella reviews investigating the health effects of e-cigarette use were conducted (September 2017 - January 2024). An international panel of subject matter experts (n = 23) and people in Canada with lived experience (n = 7) participated in a two-day, hybrid meeting, and used a consensus-based approach to develop recommendations. A guidance resource and four accompanying knowledge products were tested for usability with end users.

Results: Consensus was reached on 14 recommendations spanning four health effects: carcinogen exposure, cardiovascular health, respiratory health, and nicotine dependence. Quality of evidence was voted as ranging from high/moderate to moderate/low, and strength of most recommendations was voted as strong.

Conclusions: Guidance has been informed by best available evidence and expertise, providing direction to support decision-making. The use of established methods to evaluate divergent published literature combined with consensus-building methods among a range of stakeholders on vaping is possible. As higher quality evidence continues to emerge, recommendations will require iterative refinement.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University